Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Gisela Orozco & Anne Barton. (2010) Update on the genetic risk factors for rheumatoid arthritis. Expert Review of Clinical Immunology 6:1, pages 61-75.
Read now
Read now
Articles from other publishers (47)
Daniel H. Solomon, Olga Demler, Pamela M. Rist, Leah Santacroce, Ahmed Tawakol, Jon T. Giles, Katherine P. Liao & Joan M. Bathon. (2024) Biomarkers of Cardiovascular Risk in Patients With Rheumatoid Arthritis: Results From the TARGET Trial. Journal of the American Heart Association 13:5.
Crossref
Crossref
Elena V. Gerasimova, Tatiana V. Popkova, Daria A. Gerasimova, Yuliya V. Markina & Tatiana V. Kirichenko. (2023) Subclinical Carotid Atherosclerosis in Patients with Rheumatoid Arthritis at Low Cardiovascular Risk. Biomedicines 11:3, pages 974.
Crossref
Crossref
Dzhemal Moten, Ivanka Teneva, Desislava Apostolova, Tsvetelina Batsalova & Balik Dzhambazov. (2022) Molecular Mimicry of the Rheumatoid Arthritis-Related Immunodominant T-Cell Epitope within Type II Collagen (CII260-270) by the Bacterial L-Asparaginase. International Journal of Molecular Sciences 23:16, pages 9149.
Crossref
Crossref
Rim Sghiri, Hana Benhassine, Khadija Baccouche, Meriem Ghozzi, Sarra Jriri, Zahid Shakoor, Adel Almogren, Foued Slama, Nadia Idriss, Zeineb Benlamine, Elyes Bouajina & Ramzi Zemni. (2022) A CD40 variant is associated with systemic bone loss among patients with rheumatoid arthritis. Clinical Rheumatology 41:6, pages 1851-1858.
Crossref
Crossref
Patrick Haubruck, Marlene Magalhaes Pinto, Babak Moradi, Christopher B. Little & Rebecca Gentek. (2021) Monocytes, Macrophages, and Their Potential Niches in Synovial Joints – Therapeutic Targets in Post-Traumatic Osteoarthritis?. Frontiers in Immunology 12.
Crossref
Crossref
Eun Sook Lee, Jae Hoon Sul, Jung Min Shin, Sol Shin, Jae Ah Lee, Hark Kyun Kim, Yongeun Cho, Hyewon Ko, Soyoung Son, Jeongmi Lee, Sunyoung Park, Dong-Gyu Jo & Jae Hyung Park. (2021) Reactive oxygen species-responsive dendritic cell-derived exosomes for rheumatoid arthritis. Acta Biomaterialia 128, pages 462-473.
Crossref
Crossref
Valentina Pucino, David H Gardner & Benjamin A Fisher. (2020) Rationale for CD40 pathway blockade in autoimmune rheumatic disorders. The Lancet Rheumatology 2:5, pages e292-e301.
Crossref
Crossref
Muhammad Tarek AbdelGhafar, Rasha A. El-Kholy, Tamer A. Elbedewy, Alzahraa A. Allam, Radwa Abd Elmotaleb Eissa, Sara Mina Samy, Sara Ragab Abd El-Khalik & Hanem Rabah. (2020) Impact of CD40 gene polymorphisms on the risk of immune thrombocytopenic purpura. Gene 736, pages 144419.
Crossref
Crossref
Torsten Lowin, Tareq M. Anssar, Marina Bäuml, Tim Classen, Matthias Schneider & Georg Pongratz. (2020) Positive and negative cooperativity of TNF and Interferon-γ in regulating synovial fibroblast function and B cell survival in fibroblast/B cell co-cultures. Scientific Reports 10:1.
Crossref
Crossref
Ilce Valeria Román-Fernández, Mariel García-Chagollán, Sergio Cerpa-Cruz, Luis Felipe Jave-Suárez, Claudia Azucena Palafox-Sánchez, Samuel García-Arellano, Gabriela Athziri Sánchez-Zuno & José Francisco Muñoz-Valle. (2019) Assessment of CD40 and CD40L expression in rheumatoid arthritis patients, association with clinical features and DAS28. Clinical and Experimental Medicine 19:4, pages 427-437.
Crossref
Crossref
S -C Bae & Y H Lee. (2019) Association between CD40 polymorphisms and systemic lupus erythematosus and correlation between soluble CD40 and CD40 ligand levels in the disease: a meta-analysis. Lupus 28:12, pages 1452-1459.
Crossref
Crossref
Sudha Visvanathan, Stefan Daniluk, Rafał Ptaszyński, Ulf Müller-Ladner, Meera Ramanujam, Bernd Rosenstock, Anastasia G Eleftheraki, Richard Vinisko, Alena Petříková, Herbert Kellner, Eva Dokoupilova, Brygida Kwiatkowska, Rieke Alten, Christian Schwabe, Patrick Baum, David Joseph, Jay S Fine, Steven J Padula & Jürgen Steffgen. (2019) Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study. Annals of the Rheumatic Diseases 78:6, pages 754-760.
Crossref
Crossref
Yeniley Ruiz‐Noa, Jorge Hernández‐Bello, Mara A. Llamas‐Covarrubias, Claudia A. Palafox‐Sánchez, Edith Oregon‐Romero, Pedro Ernesto Sánchez‐Hernández, Maria Guadalupe Ramírez‐Dueñas, Isela Parra‐Rojas & Jose Francisco Muñoz‐Valle. (2018)
PTPN22
1858C>T polymorphism is associated with increased CD154 expression and higher CD4+ T cells percentage in rheumatoid arthritis patients
. Journal of Clinical Laboratory Analysis 33:3.
Crossref
Crossref
I. V. Román-Fernández, G. A. Sánchez-Zuno, J. R. Padilla-Gutiérrez, S. Cerpa-Cruz, J. Hernández-Bello, Y. Valle, M. G. Ramírez-Dueñas, C. Carrillo & J. F. Muñoz-Valle. (2017) The 3′-UTR (CA)n microsatellite on CD40LG gene as a possible genetic marker for rheumatoid arthritis in Mexican population: impact on CD40LG mRNA expression. Clinical Rheumatology 37:2, pages 345-353.
Crossref
Crossref
Chien-Hsueh Tung, Ming-Chi Lu, Ning-Sheng Lai & Shu-Fen Wu. (2017) Tumor necrosis factor-α blockade treatment decreased CD154 (CD40-ligand) expression in rheumatoid arthritis. PLOS ONE 12:8, pages e0183726.
Crossref
Crossref
Yang Xiang, Jing Guo, You-Fan Peng, Hua-Tuo Huang, Yan Lan & Ye-Sheng Wei. (2017) Association study of CD154 polymorphisms and serum CD154 level with systemic lupus erythematous in Chinese population. Rheumatology International 37:8, pages 1287-1294.
Crossref
Crossref
Michael Croft & Richard M. Siegel. (2017) Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases. Nature Reviews Rheumatology 13:4, pages 217-233.
Crossref
Crossref
Y H Lee, S-C Bae, S J Choi, J D Ji & G G Song. (2015) Associations between the functional CD40 rs4810485 G/T polymorphism and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Lupus 24:11, pages 1177-1183.
Crossref
Crossref
Ae R Noort, Paul P Tak & Sander W Tas. (2015) Non-canonical NF-κB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde?. Arthritis Research & Therapy 17:1, pages 15.
Crossref
Crossref
Vaishali R. Moulton, Kamalpreet Nagpal & George C. Tsokos. 2015. Infection and Autoimmunity. Infection and Autoimmunity
85
108
.
Jinhyun KimHyun Ji LeeIn Seol YooSeong Wook KangJae Ho Lee. (2014) Regulatory B Cells Are Inversely Associated with Disease Activity in Rheumatoid Arthritis. Yonsei Medical Journal 55:5, pages 1354.
Crossref
Crossref
P Piotrowski, M Lianeri, M Wudarski, M Olesińska & PP Jagodziński. (2012)
Single nucleotide polymorphism of
CD40
region and the risk of systemic lupus erythematosus
. Lupus 22:3, pages 233-237.
Crossref
Crossref
Nien Yee Kow & Anselm Mak. (2013) Costimulatory Pathways: Physiology and Potential Therapeutic Manipulation in Systemic Lupus Erythematosus. Clinical and Developmental Immunology 2013, pages 1-12.
Crossref
Crossref
Mercedes García-Bermúdez, Carlos González-Juanatey, Raquel López-Mejías, María Teruel, Alfonso Corrales, José A. Miranda-Filloy, Santos Castañeda, Alejandro Balsa, Benjamín Fernández-Gutierrez, Isidoro González-Álvaro, Carmen Gómez-Vaquero, Ricardo Blanco, Javier Llorca, Javier Martín & Miguel A. González-Gay. (2012) Study of Association of CD40-CD154 Gene Polymorphisms with Disease Susceptibility and Cardiovascular Risk in Spanish Rheumatoid Arthritis Patients. PLoS ONE 7:11, pages e49214.
Crossref
Crossref
Weijia Dong & Ping Zhu. (2012) Functional niche of inflamed synovium for Th17-cell expansion and activation in rheumatoid arthritis: Implication to clinical therapeutics. Autoimmunity Reviews 11:12, pages 844-851.
Crossref
Crossref
David H. WagnerJr.Jr.. (2012) The specific antigen approach in multiple sclerosis: Can it ever be enough?. Clinical Immunology 144:2, pages 139-141.
Crossref
Crossref
Dass S. Vinay & Byoung S. Kwon. (2012) Targeting TNF superfamily members for therapeutic intervention in rheumatoid arthritis. Cytokine 57:3, pages 305-312.
Crossref
Crossref
Nada Alaaeddine, Ghada S. Hassan, Daniel Yacoub & Walid Mourad. (2012) CD154: An Immunoinflammatory Mediator in Systemic Lupus Erythematosus and Rheumatoid Arthritis. Clinical and Developmental Immunology 2012, pages 1-11.
Crossref
Crossref
Ekta Rai & Edward K. Wakeland. (2011) Genetic predisposition to autoimmunity – What have we learned?. Seminars in Immunology 23:2, pages 67-83.
Crossref
Crossref
Yonghong Li & Ann B. Begovich. (2009) Unraveling the genetics of complex diseases: Susceptibility genes for rheumatoid arthritis and psoriasis. Seminars in Immunology 21:6, pages 318-327.
Crossref
Crossref
Anna L. Peters, Laura L. Stunz & Gail A. Bishop. (2009) CD40 and autoimmunity: The dark side of a great activator. Seminars in Immunology 21:5, pages 293-300.
Crossref
Crossref
Cristiana Almerighi, Anna Sinistro, Antonella Cavazza, Chiara Ciaprini, Giovanni Rocchi & Alberto Bergamini. (2009) 1?,25-Dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in Human Monocytes. Cytokine 45:3, pages 190-197.
Crossref
Crossref
Eric M. Ruderman & Richard M. Pope. 2009. New Therapeutic Targets in Rheumatoid Arthritis. New Therapeutic Targets in Rheumatoid Arthritis
27
43
.
Che-Leung Law & Iqbal S. Grewal. 2009. Therapeutic Targets of the TNF Superfamily. Therapeutic Targets of the TNF Superfamily
8
36
.
Sampath Prahalad, Thomas B Martins, Anne E Tebo, April Whiting, Bronte Clifford, Andrew S Zeft, Bernadette McNally, John F Bohnsack & Harry R Hill. (2008) Elevated serum levels of soluble CD154 in children with juvenile idiopathic arthritis. Pediatric Rheumatology 6:1.
Crossref
Crossref
Georg Pongratz & Rainer H. Straub. (2007) B-cell involvement in the pathogenesis of RA–is there a contribution of the sympathetic nervous system?. Immunologic Research 40:2, pages 148-163.
Crossref
Crossref
Ling Li, Houping Wang & Bin Wang. (2008) Anergic cells generated by blocking CD28 and CD40 costimulatory pathways in vitro ameliorate collagen induced arthritis. Cellular Immunology 254:1, pages 39-45.
Crossref
Crossref
Claire Lé;veillé;Marlène Bouillon, Wen Guo, Julie Bolduc, Ehssan Sharif-Askari, Youssef El-Fakhry, Carlos Reyes-Moreno, Rejean Lapointe, Yahye Merhi, John A. Wilkins & Walid Mourad. (2007) CD40 Ligand Binds to α5β1 Integrin and Triggers Cell Signaling. Journal of Biological Chemistry 282:8, pages 5143-5151.
Crossref
Crossref
B. Quadbeck, M. Stucke, A. K. Eckstein, D. J. Heise, K. Mann & R. K. Gieseler. (2006) Dysregulation of TNF/TNFR Superfamily Members: A Systemic Link Between Intra‐ and Extrathyroidal Manifestations in Graves’ Disease. Scandinavian Journal of Immunology 64:5, pages 523-530.
Crossref
Crossref
Aryeh M. Abeles & Michael H. Pillinger. (2006) Statins as antiinflammatory and immunomodulatory agents: A future in rheumatologic therapy?. Arthritis & Rheumatism 54:2, pages 393-407.
Crossref
Crossref
Toru Sasaki, Yoshihiko Hoshida, Jian-Xian Xu, Yasuhiko Tomita, Emi Sakane-Ishikawa, Shigeki Fujita & Katsuyuki Aozasa. (2005) Prognostic significance of CD40 expression in malignant lymphoma developing in rheumatoid arthritis. Journal of Cancer Research and Clinical Oncology 131:12.
Crossref
Crossref
Jocea M. van Amelsfort, Johannes W. J. Bijlsma & Leonie S. Taams. 2005. Regulatory T Cells in Inflammation. Regulatory T Cells in Inflammation
153
172
.
Thomas LuftEugene MaraskovskyMax SchnurrKatja KnebelMichael KirschMartin GörnerRadek SkodaAnthony D. HoPeter NawrothAngelika Bierhaus. (2004) Tuning the volume of the immune response: strength and persistence of stimulation determine migration and cytokine secretion of dendritic cells. Blood 104:4, pages 1066-1074.
Crossref
Crossref
Danielle Burger, Nicolas Molnarfi, Lyssia Gruaz & Jean-Michel Dayer. (2004) Differential Induction of IL-1β and TNF by CD40 Ligand or Cellular Contact with Stimulated T Cells Depends on the Maturation Stage of Human Monocytes. The Journal of Immunology 173:2, pages 1292-1297.
Crossref
Crossref
Dimitris Daoussis, Andrew P. Andonopoulos & Stamatis-Nick C. Liossis. (2004) Targeting CD40L: a Promising Therapeutic Approach. Clinical and Vaccine Immunology 11:4, pages 635-641.
Crossref
Crossref
Chikako Fukasawa, Yasushi Kawaguchi, Masayoshi Harigai, Tomoko Sugiura, Kae Takagi, Manabu Kawamoto, Masako Hara & Naoyuki Kamatani. (2003) Increased CD40 expression in skin fibroblasts from patients with systemic sclerosis (SSc): role of CD40‐CD154 in the phenotype of SSc fibroblasts. European Journal of Immunology 33:10, pages 2792-2800.
Crossref
Crossref
C R WANG & M F LIU. (2003)
Regulation of CCR5 expression and MIP-1
α
production in CD4+ T cells from patients with rheumatoid arthritis
. Clinical and Experimental Immunology 132:2, pages 371-378.
Crossref
Crossref